Department of Obstetrics and Gynecology, University of Health Sciences, Bursa Yuksek Ihtisas Training and Research Hospital, Bursa, Turkey.
Bursa Doruk Yildirim Hospital, Bursa, Turkey.
Biomarkers. 2022 Jul;27(5):483-487. doi: 10.1080/1354750X.2022.2064549. Epub 2022 Apr 19.
To analyse the SFRP-5 serum levels in PCOS and to investigate the relationship between SFRP-5 and other metabolic parameters in PCOS.
This is a prospective case-control study carried out in a research hospital. A total of 88 subjects including 43 patients diagnosed PCOS according to Rotterdam criteria and age -BMI matched 45 healthy controls were evaluated. Serum SFRP5, fasting blood glucose, insulin levels and HOMA-IR scores of the groups were determined and compared. The cut-off of SFRP-5 for detecting PCOS was calculated.
Serum SFRP-5 levels were lower in PCOS group compared to the controls (290.13 ± 187.66 ng/mL vs 533.03 ± 208.55 ng/mL, < 0.001). There was no correlation in the PCOS group regarding SFRP-5 and other parameters. The role of SFRP-5 to predict the PCOS risk was assessed with receiver operating curve (ROC). The sensitivity of SFRP-5 was 74.4% and the specificity was 75.6% at a threshold ≤388.38 ng/ml in PCOS.
SFRP-5 could be a beneficial marker for PCOS diagnosis, follow-up and treatment.
分析多囊卵巢综合征(PCOS)患者血清 SFRP-5 水平,并探讨其与 PCOS 患者其他代谢参数的关系。
这是在一家研究医院进行的前瞻性病例对照研究。共评估了 88 名受试者,包括 43 名根据鹿特丹标准诊断为 PCOS 的患者和 45 名年龄 -BMI 匹配的健康对照者。测定并比较了各组血清 SFRP5、空腹血糖、胰岛素水平和 HOMA-IR 评分。计算了 SFRP-5 检测 PCOS 的截断值。
与对照组相比,PCOS 组血清 SFRP-5 水平较低(290.13±187.66ng/mL 比 533.03±208.55ng/mL,<0.001)。在 PCOS 组中,SFRP-5 与其他参数之间无相关性。采用受试者工作特征曲线(ROC)评估 SFRP-5 预测 PCOS 风险的作用。SFRP-5 阈值≤388.38ng/ml 时,对 PCOS 的敏感性为 74.4%,特异性为 75.6%。
SFRP-5 可能是 PCOS 诊断、随访和治疗的有益标志物。